Decreased colonization of fecal Clostridium coccoides/Eubacterium rectale species from ulcerative colitis patients in an in vitro dynamic gut model with mucin environment.
about
Mucosa-associated Faecalibacterium prausnitzii phylotype richness is reduced in patients with inflammatory bowel disease.The HMI™ module: a new tool to study the Host-Microbiota Interaction in the human gastrointestinal tract in vitroAdvances in treatment of ulcerative colitis with herbs: from bench to bedsideQuantitatively different, yet qualitatively alike: a meta-analysis of the mouse core gut microbiome with a view towards the human gut microbiomeArabinogalactan and fructo-oligosaccharides have a different fermentation profile in the Simulator of the Human Intestinal Microbial Ecosystem (SHIME ®).Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn's disease and healthy individuals.Reprogrammed and transmissible intestinal microbiota confer diminished susceptibility to induced colitis in TMF-/- mice.Functional impacts of the intestinal microbiome in the pathogenesis of inflammatory bowel disease.In vitro colonic metabolism of coffee and chlorogenic acid results in selective changes in human faecal microbiota growth.Interindividual differences in response to treatment with butyrate-producing Butyricicoccus pullicaecorum 25-3T studied in an in vitro gut model.A Molecular-Level Landscape of Diet-Gut Microbiome Interactions: Toward Dietary Interventions Targeting Bacterial GenesDoes canine inflammatory bowel disease influence gut microbial profile and host metabolism?Fecal microbiota in pouchitis and ulcerative colitisMicrobiotas from UC patients display altered metabolism and reduced ability of LAB to colonize mucusButyrate-producing Clostridium cluster XIVa species specifically colonize mucins in an in vitro gut model.Microbiota separation and C-reactive protein elevation in treatment-naïve pediatric granulomatous Crohn disease.From meta-omics to causality: experimental models for human microbiome research.Association between Faecalibacterium prausnitzii Reduction and Inflammatory Bowel Disease: A Meta-Analysis and Systematic Review of the Literature.Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson's disease patients.Roseburia spp.: a marker of health?Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics.Changes in the Abundance of Faecalibacterium prausnitzii Phylogroups I and II in the Intestinal Mucosa of Inflammatory Bowel Disease and Patients with Colorectal Cancer.The fecal microbiota as a biomarker for disease activity in Crohn's disease.Specific members of the predominant gut microbiota predict pouchitis following colectomy and IPAA in UC.Influence of Microbiota on Intestinal Immune System in Ulcerative Colitis and Its Intervention.Microbial shifts and signatures of long-term remission in ulcerative colitis after faecal microbiota transplantation.Western Indian Rural Gut Microbial Diversity in Extreme Prakriti Endo-Phenotypes Reveals Signature Microbes.Metabolic adaptation to the aqueous leaf extract of Moringa oleifera Lam.-supplemented diet is related to the modulation of gut microbiota in mice.Alterations in the Abundance and Co-occurrence of and in the Colonic Mucosa of Inflammatory Bowel Disease Subjects
P2860
Q30988830-E5BFD44C-771E-4D70-A510-09C01FF58DB9Q33688169-B063BA50-D035-4DCD-BA7B-CDDC43D6AA48Q34366829-B9FDB3F5-9BBA-47F8-9F7D-6E82AF3F68B2Q34712628-D306B994-6CE9-4D6B-AB50-CA1402F4C34CQ34830515-EE54702D-C12B-4634-BF14-B7F9474FBA38Q34900690-A39ACADE-1300-4AE2-97C9-E2E83368CF30Q35123366-15C1754B-D635-4F17-9BAC-D2A85BBA701AQ35271319-D3E148CD-9E92-42F4-9C9C-5C22654514D5Q35586855-1AA07376-B1BE-4D75-A052-7DB0A4F780A4Q35638893-9EC3CA72-2B4A-42D5-9A52-1819679F9DD8Q35823443-15908F2E-F896-4677-A584-C67E75D6C86DQ36053333-B1633E5E-A93D-4C8F-AF7D-126FF6A11726Q36189394-EB435E2C-2B3C-4E32-884B-811399D23470Q36554337-456BB9A1-A0FE-4BDF-B380-87BFD334A5F1Q36792480-1E38F72B-A56D-43F8-8B3E-897B9B460ACDQ37267753-2358A7AA-0992-496C-A64D-BE0A53FC9247Q37677334-07F4F539-60CD-4E63-BFEF-0FFB8BBFCD8AQ37700559-F99E64F1-8C13-4451-994C-4C846345036DQ38690133-819BB45C-4399-4D6D-86AC-93E1DFD3F03DQ38764022-1AE24AB9-28E6-4D1B-B8FD-2E80A2709E09Q39065664-AF1AF71F-AA81-43B4-B2D4-1FF1E9AA56E1Q40287893-BBDDE802-C0CF-49EA-A55A-47B14379B6DCQ41447259-DEEE1760-958B-4FBD-B3F9-C35A78826EC2Q43977750-8D87EB9D-ACF3-4A4F-8C9A-CA37A96CEAD2Q46242554-61C48623-CC35-4E39-BE3B-72FD751C1ADDQ46386059-1A16BB93-D19D-4CAE-8BD7-E03D0A60AB1AQ50330914-03773406-3EAC-49EA-84C7-1455B7EB8A0FQ50928660-FD85CFC0-ED47-4B15-9BF8-B65FCEDF38B3Q58758724-70383D4F-4347-4034-A1A8-827BDED66B41
P2860
Decreased colonization of fecal Clostridium coccoides/Eubacterium rectale species from ulcerative colitis patients in an in vitro dynamic gut model with mucin environment.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Decreased colonization of feca ...... model with mucin environment.
@en
Decreased colonization of feca ...... model with mucin environment.
@nl
type
label
Decreased colonization of feca ...... model with mucin environment.
@en
Decreased colonization of feca ...... model with mucin environment.
@nl
prefLabel
Decreased colonization of feca ...... model with mucin environment.
@en
Decreased colonization of feca ...... model with mucin environment.
@nl
P2093
P2860
P1476
Decreased colonization of feca ...... model with mucin environment.
@en
P2093
Joan Vermeiren
Louise Kristine Vigsnaes
Martine De Vos
Pieter Van den Abbeele
Tom Van de Wiele
P2860
P304
P356
10.1111/J.1574-6941.2011.01252.X
P577
2011-12-02T00:00:00Z